RESPONSE BIOMEDICAL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-05-19: Reporting owner Kinnaird-Steen Barbara; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-05-19: Reporting owner Adams William J.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-03-19: Reporting owner Kinnaird-Steen Barbara; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-03-19: Reporting owner SEVERSON CLINTON; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-05-19 | Kinnaird-Steen Barbara Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.72 exercise price | 2015-05-21 | |
| 2015-05-19 | Adams William J. Officer (CFO & Corporate Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.72 exercise price | 2015-05-21 | |
| 2015-03-19 | Kinnaird-Steen Barbara Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | SEVERSON CLINTON Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | Thompson Peter A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | HOLLER ANTHONY F Director, Officer (Interim CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | Adams William J. Officer (CFO & Corporate Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,500 34,500 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | KEEGAN JOSEPH D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | Shuster Lewis Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.92 exercise price | 2015-03-23 | |
| 2015-03-19 | Wang Jonathan Jian Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.92 exercise price | 2015-03-23 |